Carlyle ends boardroom spat at India's Metropolis

The US private equity firm's purchase of a stake in the pathology laboratories chain signals an end to a boardroom battle triggered by Warburg Pincus' exit earlier this year.

Carlyle ends boardroom spat at India's Metropolis

The Carlyle Group said on Wednesday it had acquired a stake in Metropolis Healthcare, a chain of pathology laboratories in India, signaling an end to a boardroom battle between the founders. 

Rival private equity firm Warburg Pincus sold its 27% stake in Metropolis in April to the Shah family which triggered a change of control and the end of a long-running power struggle between the founders, Sushil Shah and GSK Velu. 

...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: carlyle | health | private equity | india | acquisitions

Print Edition

FinanceAsia Print Edition

EVENTS